| Accession |
PRJCA001124 |
| Title |
Chinese Prostate Cancer Genome and Epigenome Atlas |
| Relevance |
Medical |
| Data types |
Whole genome sequencing
Epigenomics
|
| Organisms |
Homo sapiens
|
| Description |
Chinese Prostate Cancer Genome and Epigenome Atlas, CPGEA, is the largest and most comprehensive cancer genomics study conducted in China. Our genome and epigenome roadmap of prostate cancer for Chinese men is consisted of over 1200 genomic datasets from more than 200 pairs of match normal and primary prostate cancers, providing an invaluable resource and opportunity to complement and compare to previous cancer genomics studies represented by TCGA. |
| Sample scope |
Multiisolate |
| Release date |
2018-11-16 |
| Publication |
| PubMed ID |
Article title |
Journal name |
DOI |
Year |
| 32238934
|
A genomic and epigenomic atlas of prostate cancer in Asian populations
|
Nature
|
10.1038/s41586-020-2135-x
|
2020
|
| 33414463
|
KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer
|
Cell Death & Disease
|
10.1038/s41419-020-03354-4
|
2021
|
|
|
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| Zhangjiang National Innovation Demonstration Zone
|
Province
|
N/A
|
the "Zhangjiang National Innovation Demonstration Zone" Initiative Development Fund
|
| Ministry of Science and Technology of the People's Republic of China (MOST)
|
|
2016YFC0902200
|
Key Research and Development Project on Precision Medicine
|
| Shanghai
|
|
14DZ2272300
|
the Shanghai Key Laboratory of Cell Engineering
|
| Shanghai
|
|
2017ZZ01005
|
Top Priority Medical Center Project
|
| 13th Five-Year Plan
|
|
2017ZX093040300002
|
National Major New Drug Discovery Initiative
|
| National Natural Science Foundation of China (NSFC)
|
|
81602467
|
|
|
|
| Submitter |
Jing
Li (ljing@smmu.edu.cn)
|
| Organization |
Second Military Medical University |
| Submission date |
2018-11-16 |
